Jinxin Fertility (锦欣生殖) IPO - Worth a Look Given the Sector, Existing Shareholders and Cornerstone
Jinxin Fertility Co Ltd (1659778D CH) plans to raise up to US$390m in its Hong Kong IPO. Ke Yan, CFA, FRM has covered most details of the company...
846 Views
Jinxin Fertility Group IPO Preview: Baby Boom or Bust?
Jinxin Fertility Co Ltd (1659778D CH) is a leading assisted reproductive service (ARS) provider in China and the US. Its network of ARS medical...
923 Views
Frontage Holdings (方达控股) Post-IPO Trading Update: Strong Demand and Volume but Fairly Valued
Frontage Holdings IPO attracted strong demand and was priced at the high end of the IPO pricing. In our previous insight, we have discussed that...
611 Views
Frontage Holdings IPO: Bull/Bear Case DCF Scenarios
Frontage Holdings (1521 HK) is a global contract research organisation (CRO) which is backed by Hangzhou Tigermed Consulting (300347 CH)....
633 Views
Frontage Holdings IPO: Risk-Reward Is Favourable at the Low-End of Price Range
Frontage Holdings (1521 HK) has launched its Hong Kong IPO at a price range of HK$2.55-3.20 per share to raise HK$1.27-1.60 billion ($160-200...
766 Views